Witz IP - Search Results

1

Microenvironmental factors regulate Ly-6 A/E expression on PyV-transformed BALB/c 3T3 cells.

Eshel R, Firon M, Katz BZ, Sagi-Assif O, Aviram H, Witz IP. Eshel R, et al. Among authors: witz ip. Immunol Lett. 1995 Jan;44(2-3):209-12. doi: 10.1016/0165-2478(94)00216-e. Immunol Lett. 1995. PMID: 7797253

2

FcR may function as a progression factor of nonlymphoid tumors.

Witz IP, Ran M. Witz IP, et al. Immunol Res. 1992;11(3-4):283-95. doi: 10.1007/BF02919134. Immunol Res. 1992. PMID: 1287122 Review.

3

In vivo tumorigenicity and in vitro sensitivity to tumor-necrosis-factor alpha mediated killing of c-Ha-ras-transformed cells.

Gonen B, Kahana O, Witz IP. Gonen B, et al. Among authors: witz ip. Cancer Immunol Immunother. 1992;35(6):388-94. doi: 10.1007/BF01789017. Cancer Immunol Immunother. 1992. PMID: 1327528 Free PMC article.

4

Phenotypic properties of 3T3 cells transformed in vitro with polyoma virus and passaged once in syngeneic animals.

Langer AB, Emmanuel N, Even J, Fridman WH, Gohar O, Gonen B, Katz BZ, Ran M, Smorodinsky NI, Witz IP. Langer AB, et al. Among authors: witz ip. Immunobiology. 1992 Aug;185(2-4):281-91. doi: 10.1016/S0171-2985(11)80646-7. Immunobiology. 1992. PMID: 1333442

5

In vivo acquisition of Fc gamma RII expression on polyoma virus-transformed cells derived from tumors of long latency.

Ran M, Katz B, Kimchi N, Halachmi E, Teillaud JL, Even J, Berko-Flint Y, Atlas E, Fridman WH, Witz IP. Ran M, et al. Among authors: witz ip. Cancer Res. 1991 Jan 15;51(2):612-8. Cancer Res. 1991. PMID: 1845956

6

Some cellular and molecular characteristics of high and low tumorigenicity variants of polyoma-virus transformed cells.

Berko-Flint Y, Fridman WH, Grossman-Atlas E, Kimchi N, Ben-Baruch AL, Moss S, Teillaud JL, Witz IP, Ran M. Berko-Flint Y, et al. Among authors: witz ip. Mol Immunol. 1990 Dec;27(12):1219-28. doi: 10.1016/0161-5890(90)90025-u. Mol Immunol. 1990. PMID: 2177146

7

Further studies on the determinant recognized by naturally-occurring murine autoantibodies reacting with bromelain-treated erythrocytes.

Serban D, Witz IP. Serban D, et al. Among authors: witz ip. Immunol Lett. 1988 Jul;18(3):191-200. doi: 10.1016/0165-2478(88)90018-1. Immunol Lett. 1988. PMID: 2459052

8

Differential tumorigenicity of 3T3 cells transformed in vitro with polyoma virus and in vivo selection for high tumorigenicity.

Halachmi E, Witz IP. Halachmi E, et al. Among authors: witz ip. Cancer Res. 1989 May 1;49(9):2383-9. Cancer Res. 1989. PMID: 2539901

9

Increased expression of Fc gamma receptor in cancer patients and tumor bearing mice.

Ran M, Teillaud JL, Fridman WH, Frenkel H, Halachmi E, Katz B, Gips M, Shlomo Y, Barzilay J, Witz IP. Ran M, et al. Among authors: witz ip. Mol Immunol. 1988 Nov;25(11):1159-67. doi: 10.1016/0161-5890(88)90151-4. Mol Immunol. 1988. PMID: 2851735

10

Some immunological properties of high and low tumorigenic cellular variants of c-H-ras transformed 3T3 cells.

Gonen B, Ran M, Wreschner D, Cahalon L, Anavi R, Shlomo Y, Witz IP. Gonen B, et al. Among authors: witz ip. Nat Immun Cell Growth Regul. 1988;7(3):144-54. Nat Immun Cell Growth Regul. 1988. PMID: 3050475

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters